Cinnabloc Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Cinnarizine

Indications/Uses

Symptomatic treatment of nausea & vertigo caused by Meniere's disease & other vestibular disorder. Prevention & treatment of motion sickness. Peripheral & cerebral vascular disorder.

Click to view Cinnabloc detailed prescribing information

Dosage/Direction for Use

Cerebral circulation disorder 1 cap daily or 1-2 tab tid. Peripheral circulation disorder 1 cap daily or 1-3 tab tid. Vestibular disturbances 1 cap daily or 1 tab tid. Motion sickness 1 cap daily up to a max of 225 mg daily or ½-1 tab before traveling, repeated every 6 hr.

Click to view Cinnabloc detailed prescribing information

Administration

Should be taken with food.

Special Precautions

Premature infants or neonates. May suppress cutaneous histamine response to allergen extr & should be discontinued several days before skin testing.

Click to view Cinnabloc detailed prescribing information

Adverse Reactions

Convulsions.

Click to view Cinnabloc detailed prescribing information

Drug Interactions

May enhance sedative effects of CNS depressants including alcohol, barbiturates, hypnotics, opioid analgesics, anxiolytic sedatives & antipsychotics. Additive antimuscarinic action w/ other antimuscarinic drugs eg, atropine & some antidepressants. Hazardous ventricular arrhythmias w/ nonsedating antihistamines astemizole & terfenadine. May mask warning signs of damage caused by ototoxic drugs eg, aminoglycosides.

Click to view Cinnabloc detailed prescribing information

Storage

View Cinnabloc storage conditions for details to ensure optimal shelf-life.

Description

View Cinnabloc description for details of the chemical structure and excipients (inactive components).

Action

View Cinnabloc mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antivertigo Drugs / Peripheral Vasodilators & Cerebral Activators

ATC Classification

N07CA02 - cinnarizine ; Belongs to the class of antivertigo preparations.

Regulatory Classification

Presentation/Packing

Form

Cinnabloc cap 75 mg

Packing/Price

10's

Form

Cinnabloc tab 25 mg

Packing/Price

100's

Cinnabloc

cinnarizine

Manufacturer:

Lloyd

Distributor:

Aldril